BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: von Kampen O, Buch S, Nothnagel M, Azocar L, Molina H, Brosch M, Erhart W, von Schönfels W, Egberts J, Seeger M, Arlt A, Balschun T, Franke A, Lerch MM, Mayerle J, Kratzer W, Boehm BO, Huse K, Schniewind B, Tiemann K, Jiang ZY, Han TQ, Mittal B, Srivastava A, Fenger M, Jørgensen T, Schirin-Sokhan R, Tönjes A, Wittenburg H, Stumvoll M, Kalthoff H, Lammert F, Tepel J, Puschel K, Becker T, Schreiber S, Platzer M, Völzke H, Krawczak M, Miquel JF, Schafmayer C, Hampe J. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus. Hepatology 2013;57:2407-17. [PMID: 22898925 DOI: 10.1002/hep.26009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu GQ, Xu CF, Chen HT, Liu S, Teng XD, Xu GY, Yu CH. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. World J Gastroenterol 2014; 20(28): 9513-9518 [PMID: 25071346 DOI: 10.3748/wjg.v20.i28.9513] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
2 Joshi AD, Andersson C, Buch S, Stender S, Noordam R, Weng LC, Weeke PE, Auer PL, Boehm B, Chen C, Choi H, Curhan G, Denny JC, De Vivo I, Eicher JD, Ellinghaus D, Folsom AR, Fuchs C, Gala M, Haessler J, Hofman A, Hu F, Hunter DJ, Janssen HL, Kang JH, Kooperberg C, Kraft P, Kratzer W, Lieb W, Lutsey PL, Darwish Murad S, Nordestgaard BG, Pasquale LR, Reiner AP, Ridker PM, Rimm E, Rose LM, Shaffer CM, Schafmayer C, Tamimi RM, Uitterlinden AG, Völker U, Völzke H, Wakabayashi Y, Wiggs JL, Zhu J, Roden DM, Stricker BH, Tang W, Teumer A, Hampe J, Tybjærg-Hansen A, Chasman DI, Chan AT, Johnson AD. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology 2016;151:351-363.e28. [PMID: 27094239 DOI: 10.1053/j.gastro.2016.04.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
3 Di Ciaula A, Wang DQ, Portincasa P. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention. Expert Rev Gastroenterol Hepatol 2019;13:157-71. [PMID: 30791781 DOI: 10.1080/17474124.2019.1549988] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
4 Dikkers A, Tietge UJ. The neglected cousin of the hepatocyte: how gallbladder epithelial cells might contribute to cholesterol gallstone formation. Dig Dis Sci 2013;58:296-8. [PMID: 23371007 DOI: 10.1007/s10620-012-2541-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Hirobe-Jahn S, Harsch S, Renner O, Richter D, Müller O, Stange EF. Association of FXR gene variants with cholelithiasis. Clin Res Hepatol Gastroenterol 2015;39:68-79. [PMID: 25242139 DOI: 10.1016/j.clinre.2014.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Goodloe R, Brown-Gentry K, Gillani NB, Jin H, Mayo P, Allen M, McClellan B Jr, Boston J, Sutcliffe C, Schnetz-Boutaud N, Dilks HH, Crawford DC. Lipid trait-associated genetic variation is associated with gallstone disease in the diverse Third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet 2013;14:120. [PMID: 24256507 DOI: 10.1186/1471-2350-14-120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Helgadottir A, Sulem P, Thorgeirsson G, Gretarsdottir S, Thorleifsson G, Jensson BÖ, Arnadottir GA, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K. Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J 2018;39:2172-8. [PMID: 29596577 DOI: 10.1093/eurheartj/ehy169] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
8 Bustos BI, Pérez-Palma E, Buch S, Azócar L, Riveras E, Ugarte GD, Toliat M, Nürnberg P, Lieb W, Franke A, Hinz S, Burmeister G, von Schönfels W, Schafmayer C, Völzke H, Völker U, Homuth G, Lerch MM, Santos JL, Puschel K, Bambs C, Roa JC, Gutiérrez RA, Hampe J, De Ferrari GV, Miquel JF. Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestry. Sci Rep 2019;9:772. [PMID: 30692554 DOI: 10.1038/s41598-018-35852-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
9 Wang HH, Liu M, Portincasa P, Wang DQ. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease. Adv Exp Med Biol 2020;1276:105-36. [PMID: 32705597 DOI: 10.1007/978-981-15-6082-8_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Frigerio P, Cepeda-Nieto AC, Marcos-Morales S, Peña-Velázquez A, Dávila-Flores S, Salinas-Santander M. Distribution of the ATP-binding cassette transporter ABCG8 IVS1-2A>G genotype and clinical characteristics of gallbladder patients in Northeastern Mexico: A pilot study. Biomed Rep 2018;9:266-70. [PMID: 30271604 DOI: 10.3892/br.2018.1123] [Reference Citation Analysis]
11 Yoon JH, Choi HS, Jun DW, Yoo KS, Lee J, Yang SY, Kuver R. ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder. Dig Dis Sci 2013;58:431-9. [PMID: 23179156 DOI: 10.1007/s10620-012-2481-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
12 Di Ciaula A, Wang DQ, Portincasa P. An update on the pathogenesis of cholesterol gallstone disease. Curr Opin Gastroenterol 2018;34:71-80. [PMID: 29283909 DOI: 10.1097/MOG.0000000000000423] [Cited by in Crossref: 66] [Cited by in F6Publishing: 49] [Article Influence: 22.0] [Reference Citation Analysis]
13 Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 2016;1865:245-54. [PMID: 26980625 DOI: 10.1016/j.bbcan.2016.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
14 Wang HH, Li T, Portincasa P, Ford DA, Neuschwander-Tetri BA, Tso P, Wang DQ. New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Res 2017;1:42-53. [PMID: 34367715 DOI: 10.1016/j.livres.2017.05.005] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
15 Zein AA, Kaur R, Hussein TOK, Graf GA, Lee JY. ABCG5/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion. Biochem Soc Trans 2019;47:1259-68. [PMID: 31654053 DOI: 10.1042/BST20190130] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
16 Wang TY, Portincasa P, Liu M, Tso P, Wang DQ. Mouse models of gallstone disease. Curr Opin Gastroenterol 2018;34:59-70. [PMID: 29266008 DOI: 10.1097/MOG.0000000000000417] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
17 Castro-torres IG, Cárdenas-vázquez RDJ, Velázquez-gonzález C, Ventura-martínez R, De la O-arciniega M, Naranjo-rodríguez EB, Martínez-vázquez M. Future therapeutic targets for the treatment and prevention of cholesterol gallstones. European Journal of Pharmacology 2015;765:366-74. [DOI: 10.1016/j.ejphar.2015.08.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Chauhan T, Mittal RD, Mittal B. Association of Common Single Nucleotide Polymorphisms of Candidate Genes with Gallstone Disease: A Meta-Analysis. Indian J Clin Biochem 2020;35:290-311. [PMID: 32647408 DOI: 10.1007/s12291-019-00832-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wang HH, Portincasa P, Liu M, Wang DQ. Genetic Analysis of ABCB4 Mutations and Variants Related to the Pathogenesis and Pathophysiology of Low Phospholipid-Associated Cholelithiasis. Genes (Basel) 2022;13:1047. [PMID: 35741809 DOI: 10.3390/genes13061047] [Reference Citation Analysis]
20 de Bari O, Wang HH, Portincasa P, Liu M, Wang DQ. The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice. Biochim Biophys Acta 2015;1852:2161-9. [PMID: 26232687 DOI: 10.1016/j.bbadis.2015.07.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
21 Koshiol J, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA. Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. Cytokine 2016;83:217-25. [PMID: 27173614 DOI: 10.1016/j.cyto.2016.05.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
22 Kleinlützum D, Plesker R. A case of gallstones in an African green monkey (Chlorocebus aethiops). Primate Biol 2017;4:33-7. [PMID: 32110690 DOI: 10.5194/pb-4-33-2017] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Zhao F, Ma S, Zhou Y, Wei B, Hao Z, Cui X, Xing L, Liu G, Jin L, Ma T, Shi L. miRNA-223 Suppresses Mouse Gallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway. Int J Biol Sci 2021;17:4459-73. [PMID: 34803510 DOI: 10.7150/ijbs.65485] [Reference Citation Analysis]
24 Wang DQ, Neuschwander-tetri BA, Portincasa P. The Biliary System, Second Edition. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2016;8:i-178. [DOI: 10.4199/c00147ed2v01y201611isp071] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Feng X, Zhu C, Lee S, Gao J, Zhu P, Yamauchi J, Pan C, Singh S, Qu S, Miller R, Monga SP, Peng Y, Dong HH. Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice. J Biol Chem 2020;295:7003-17. [PMID: 32273342 DOI: 10.1074/jbc.RA119.012272] [Reference Citation Analysis]
26 Stender S, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease. J Am Coll Cardiol. 2014;63:2121-2128. [PMID: 24657701 DOI: 10.1016/j.jacc.2013.12.055] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
27 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
28 Kroll T, Prescher M, Smits SHJ, Schmitt L. Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chem Rev 2021;121:5240-88. [PMID: 33201677 DOI: 10.1021/acs.chemrev.0c00659] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
29 Bhatia R, Thompson C, Ganguly K, Singh S, Batra SK, Kumar S. Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis. Cells 2020;9:E1880. [PMID: 32796685 DOI: 10.3390/cells9081880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Wang HH, Li X, Patel SB, Wang DQ. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice. Hepatology 2016;64:853-64. [PMID: 27014967 DOI: 10.1002/hep.28570] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
31 Hancock-Cerutti W, Rader DJ. Opposing effects of ABCG5/8 function on myocardial infarction and gallstone disease. J Am Coll Cardiol 2014;63:2129-30. [PMID: 24657684 DOI: 10.1016/j.jacc.2014.02.553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Ferkingstad E, Oddsson A, Gretarsdottir S, Benonisdottir S, Thorleifsson G, Deaton AM, Jonsson S, Stefansson OA, Norddahl GL, Zink F, Arnadottir GA, Gunnarsson B, Halldorsson GH, Helgadottir A, Jensson BO, Kristjansson RP, Sveinbjornsson G, Sverrisson DA, Masson G, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Holm H, Jonsdottir I, Olafsson S, Steingrimsdottir T, Rafnar T, Bjornsson ES, Thorsteinsdottir U, Gudbjartsson DF, Sulem P, Stefansson K. Genome-wide association meta-analysis yields 20 loci associated with gallstone disease. Nat Commun 2018;9:5101. [PMID: 30504769 DOI: 10.1038/s41467-018-07460-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
33 Williams K, Segard A, Graf GA. Sitosterolemia: Twenty Years of Discovery of the Function of ABCG5ABCG8. Int J Mol Sci 2021;22:2641. [PMID: 33807969 DOI: 10.3390/ijms22052641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Aamann L, Ørntoft N, Vogel I, Grønbaek H, Becher N, Vilstrup H, Ott P, Lildballe DL. Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination. Scand J Gastroenterol 2018;53:305-11. [PMID: 29304564 DOI: 10.1080/00365521.2017.1422800] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Pérez-moreno P, Riquelme I, García P, Brebi P, Roa JC. Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer. JPM 2022;12:234. [DOI: 10.3390/jpm12020234] [Reference Citation Analysis]
36 Dietrich CG, Geier A. Effect of drug transporter pharmacogenetics on cholestasis. Expert Opin Drug Metab Toxicol. 2014;10:1533-1551. [PMID: 25260651 DOI: 10.1517/17425255.2014.963553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
37 Cai JS, Chen JH. The mechanism of enterohepatic circulation in the formation of gallstone disease. J Membr Biol 2014;247:1067-82. [PMID: 25107305 DOI: 10.1007/s00232-014-9715-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
38 Han SJ, Chang JH, Gweon TG, Kim TH, Kim HK, Kim CW. Analysis of symptomatic recurrences of common bile ducts stones after endoscopic removal: Factors related to early or multiple recurrences. Medicine (Baltimore) 2022;101:e28671. [PMID: 35060565 DOI: 10.1097/MD.0000000000028671] [Reference Citation Analysis]
39 Pek SLT, Dissanayake S, Fong JCW, Lin MX, Chan EZL, Tang JI, Lee CW, Ong HY, Sum CF, Lim SC, Tavintharan S. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study. Atherosclerosis 2018;269:106-16. [PMID: 29353225 DOI: 10.1016/j.atherosclerosis.2017.12.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
40 Liang KW, Huang HH, Wang L, Lu WY, Chou YH, Tantoh DM, Nfor ON, Chiu NY, Tyan YS, Liaw YP. Risk of gallstones based on ABCG8 rs11887534 single nucleotide polymorphism among Taiwanese men and women. BMC Gastroenterol 2021;21:468. [PMID: 34906072 DOI: 10.1186/s12876-021-02060-5] [Reference Citation Analysis]
41 Pérez-Palma E, Bustos BI, Lal D, Buch S, Azocar L, Toliat MR, Lieb W, Franke A, Hinz S, Burmeister G, von Shönfels W, Schafmayer C, Ahnert P, Völzke H, Völker U, Homuth G, Lerch MM, Puschel K, Gutiérrez RA, Hampe J, Nürnberg P, Miquel JF, De Ferrari GV. Copy number variants in lipid metabolism genes are associated with gallstones disease in men. Eur J Hum Genet 2020;28:264-73. [PMID: 31485028 DOI: 10.1038/s41431-019-0501-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
42 Jiang ZY, Cai Q, Chen EZ. Association of three common single nucleotide polymorphisms of ATP binding cassette G8 gene with gallstone disease: a meta-analysis. PLoS One 2014;9:e87200. [PMID: 24498041 DOI: 10.1371/journal.pone.0087200] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
43 Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013;34:3959-3966. [PMID: 23838803 DOI: 10.1007/s13277-013-0984-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
44 Wang B, Huang A, Jiang M, Li H, Bao W, Ding K, Jiang Z, Zhao G, Hu H. Risk Factors for Early Recurrence of Gallstones in Patients Undergoing Laparoscopy Combined With Choledochoscopic Lithotomy: A Single-Center Prospective Study. Front Surg 2021;8:759390. [PMID: 34901141 DOI: 10.3389/fsurg.2021.759390] [Reference Citation Analysis]
45 Patel SB. Recent advances in understanding the STSL locus and ABCG5/ABCG8 biology: . Current Opinion in Lipidology 2014;25:169-75. [DOI: 10.1097/mol.0000000000000071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
46 Koivusalo A, Mutanen A, Nissinen M, Gylling H, Pakarinen M. Altered Bile Transporter Expression and Cholesterol Metabolism in Children With Cholesterol and Pigment Gallstones. J Pediatr Gastroenterol Nutr 2019;69:138-44. [PMID: 31169656 DOI: 10.1097/MPG.0000000000002353] [Reference Citation Analysis]
47 Wang DQ, Portincasa P, Wang HH. Bile Formation and Pathophysiology of Gallstones. Encyclopedia of Gastroenterology. Elsevier; 2020. pp. 287-306. [DOI: 10.1016/b978-0-12-801238-3.65861-0] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Rebholz C, Krawczyk M, Lammert F. Genetics of gallstone disease. Eur J Clin Invest 2018;48:e12935. [DOI: 10.1111/eci.12935] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]